Holen Sie sich die Stockscreener-App
194.06
0.30%
-0.635
Schlusskurs vom Vortag:
$194.70
Offen:
$194.7
24-Stunden-Volumen:
262.57K
Relative Volume:
0.21
Marktkapitalisierung:
$10.13B
Einnahmen:
$45.08B
Nettoeinkommen (Verlust:
$188.00M
KGV:
57.23
EPS:
3.3907
Netto-Cashflow:
$251.00M
1W Leistung:
-1.74%
1M Leistung:
-15.12%
6M Leistung:
+8.09%
1J Leistung:
+22.96%
1-Tages-Spanne:
$192.83
$195.77
1-Wochen-Bereich:
$186.04
$204.81
52-Wochen-Spanne:
$121.06
$244.89
Molina Healthcare Inc Stock (MOH) Company Profile
Firmenname
Molina Healthcare Inc
Sektor
Branche
Telefon
(562) 435-3666
Adresse
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MOH
Molina Healthcare Inc
|
193.98 | 10.41B | 45.08B | 188.00M | 251.00M | 3.3907 |
UNH
Unitedhealth Group Inc
|
418.11 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
105.14 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
376.56 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.49 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
365.68 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-24 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-10-16 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-25 | Herabstufung | Truist | Buy → Hold |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-04-22 | Eingeleitet | Bernstein | Outperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-03 | Fortgesetzt | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-11-22 | Fortgesetzt | Deutsche Bank | Hold |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Underweight |
| 2021-03-30 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-10 | Eingeleitet | Mizuho | Buy |
| 2021-02-19 | Fortgesetzt | Barclays | Overweight |
| 2021-01-21 | Eingeleitet | Goldman | Neutral |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-16 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2020-04-08 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2019-10-30 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-07-31 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-03 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-05-31 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-04-30 | Bestätigt | BofA/Merrill | Underperform |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-13 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-10 | Eingeleitet | Evercore ISI | In-line |
| 2018-06-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-06-22 | Hochstufung | Jefferies | Hold → Buy |
| 2018-03-28 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-16 | Hochstufung | JP Morgan | Neutral → Overweight |
Alle ansehen
Molina Healthcare Inc Aktie (MOH) Neueste Nachrichten
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
The MolinaCares Accord Invests $50,000 to Expand Fresh for Learning and Fresh for Seniors Programs - Business Wire
MOH|Molina Healthcare Inc|Price:199.480|Chg%:+1.930 - TradingKey
Molina Healthcare Inc (MOH) Institutional Confidence - TradingKey
Molina Healthcare Inc (MOH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MOLINA HEALTHCARE INC : JP MORGAN RAISES TARGET PRICE TO $220 FROM $191 - Bitget
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect - ACCESS Newswire
Molina Healthcare Inc (MOH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
2026-07-26 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Connect | NYSE:MOH | Press Release - Stockhouse
Molina Healthcare Inc (MOH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Molina Healthcare stock trades steadily as Medicaid focus supports earnings and growth outlook - Ad-hoc-news.de
Molina Healthcare, Inc. Revenue Breakdown – SWB:MHG - TradingView
Molina Healthcare, Inc. Revenue Breakdown – XETR:MHG - TradingView
Cantor Fitzgerald maintains Molina Healthcare stock rating at Neutral - Investing.com UK
Molina Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch
Molina Healthcare, Inc. Q2 2026 Financial Results: Revenue, Earnings, and Market Insights from Form 10-Q - Minichart
Molina Healthcare Facing Marketplace, Medicaid Headwinds, RBC Says - Moomoo
Cantor Fitzgerald maintains Molina Healthcare stock rating at Neutral By Investing.com - Investing.com Nigeria
Are Investors Undervaluing Molina Healthcare (MOH) Right Now? - Yahoo Finance
Deutsche Bank Adjusts Molina Healthcare Price Target to $147 From $129, Maintains Hold Rating - marketscreener.com
Truist Cuts Price Target on Molina Healthcare to $225 From $250, Keeps Hold Rating - marketscreener.com
RBC Lowers Price Target on Molina Healthcare to $218 From $248, Keeps Sector Perform Rating - marketscreener.com
Molina Healthcare Inc (MOH) Stock Forecasts - Yahoo! Finance Canada
Molina Healthcare stock trades steadily as Medicaid and marketplace growth support margins - Ad-hoc-news.de
MOH|Molina Healthcare Inc|Price:197.550|Chg%:-2.630 - TradingKey
MOLINA HEALTHCARE INC : RBC CUTS TARGET PRICE TO $218 FROM $248 - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
MOH5939488 Bond Risk Profile - TradingView
MOH5939488 Bond Coupon Profile — Rate & Payments - TradingView
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $212.53, Implies 4% Downside - TradingView
Is Molina Healthcare Inc (MOH) a Bargain After 9.7% Drop? GF Val - GuruFocus
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Molina Healthcare sharply cuts its Obamacare business as costs rise - marketscreener.com
Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: St - GuruFocus
Molina Healthcare (MOH) Reports Strong Earnings but Shares Decli - GuruFocus
Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: Strong Medicaid Performance Amid ... - Yahoo Finance
MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised - TradingView
Why Is Molina Healthcare Stock Sinking Thursday?Molina Healthcare (NYSE:MOH) - Benzinga
Molina Healthcare | 8-K: Molina Healthcare Reports Second Quarter 2026 Financial Results - Moomoo
Molina plummets as it expects to halve its Obamacare presence - Reuters
Molina Faces Very High Uncertainty Around a Range of Potential Profit Scenarios - Morningstar
Molina Healthcare Announces Q2 2026 Financial Results and Updates on Investment Portfolio - Kalkine Media
Molina stock falls despite Q2 beat (MOH:NYSE) - Seeking Alpha
Form 10-Q MOLINA HEALTHCARE, INC. For: Jun 30 - StreetInsider
Molina Healthcare Tops Q2 2026 Profit Forecast With $1.51 EPS - AlphaStreet
Earnings call transcript: Molina Healthcare beats Q2 2026 EPS, shares fall premarket - Investing.com
Molina Healthcare, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BofA Securities Adjusts Molina Healthcare Price Target to $260 From $250 - marketscreener.com
Q2 2026 Molina Healthcare Inc Earnings Call Transcript - GuruFocus
Molina Healthcare Releases Q2 2026 Financial Results - AlphaStreet
Molina Healthcare (MOH) Stock Confronts Volatile Margins After Q2 Profit And Trailing Loss - Sahm
Finanzdaten der Molina Healthcare Inc-Aktie (MOH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
14.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):